MaxCyte Inc (MXCT NASDAQ) stock market data APIs
$1.4621
0.11(7.5%)
as of December 5, 2025
Try our APIs with
free plan!
MaxCyte Inc Financial Data Overview
Price chart is built with
Anychart
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Prev. Close
1.4621
Open
1.5724
High
1.6412
Low
1.4249
52 wk Range
1.26-5.2
Market Cap
157 M
Shares Outstanding
107 M
Revenue
34 419 K
EPS
-0.12
Beta
0.32
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with MaxCyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MaxCyte Inc data using free add-ons & libraries
Get MaxCyte Inc Fundamental Data
MaxCyte Inc Fundamental data includes:
- Net Revenue: 34 419 K
- EBITDA: -46 208 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.1133
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MaxCyte Inc News
New
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO
Pictured: Cellares Chief Commercial Officer Ali Soleymannezhad Industry veteran brings two decades of platform commercialization experience in cell therapy, bioprocessing, and bioanalytics as Cellare...
MaxCyte reports Q3 results
* MaxCyte press release [https://investors.maxcyte.com/news-releases/news-release-details/maxcyte-reports-third-quarter-2025-financial-results-and] (MXCT [https://seekingalpha.com/symbol/MXCT]): Q3 ...
MaxCyte outlines $17M–$19M annualized savings through restructuring while reiterating SPL revenue guidance
Earnings Call Insights: MaxCyte (MXCT) Q3 2025 MANAGEMENT VIEW * CEO Maher Masoud reported $6.8 million in total revenue for the third quarter, including $6.4 million in core revenue and $0.4 mill...
MaxCyte CFO to step down in first half of 2026
* MaxCyte (MXCT [https://seekingalpha.com/symbol/MXCT]) announced [https://seekingalpha.com/pr/20305110-maxcyte-announces-planned-cfo-transition-in-2026] that chief financial officer Douglas Swirsky...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
